Kohlberg Kravis Roberts & Co’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $573M | Sell |
|
|||||
|
2025
Q1 | $666M | Sell |
|
|||||
|
2024
Q4 | $693M | Hold |
|
|||||
|
2024
Q3 | $643M | Sell |
|
|||||
|
2024
Q2 | $787M | Hold |
|
|||||
|
2024
Q1 | $960M | Hold |
|
|||||
|
2023
Q4 | $1.25B | Hold |
|
|||||
|
2023
Q3 | $819M | Hold |
|
|||||
|
2023
Q2 | $534M | Hold |
|
|||||
|
2023
Q1 | $515M | Hold |
|
|||||
|
2022
Q4 | $237M | Hold |
|
|||||
|
2022
Q3 | $309M | Hold |
|
|||||
|
2022
Q2 | $282M | Hold |
|
|||||
|
2022
Q1 | $315M | Hold |
|
|||||
|
2021
Q4 | $518M | Hold |
|
|||||
|
2021
Q3 | $1.46B | Hold |
|
|||||
|
2021
Q2 | $1.89B | Hold |
|
|||||
|
2021
Q1 | $1.91B | Sell |
|
|||||
|
2020
Q4 | $2.45B | Hold |
|
|||||
|
2020
Q3 | $1.29B | Hold |
|
|||||
|
2020
Q2 | $1.13B | Sell |
|
|||||
|
2020
Q1 | $1.07B | Hold |
|
|||||
|
2019
Q4 | $1.29B | Hold |
|
|||||
|
2019
Q3 | $792M | Hold |
|
|||||
|
2019
Q2 | $995M | Buy |
|